For some retirees, resilience comes with this new phase of life. They carry with them years of experience, professional accomplishments and just living life. And for some, living near others like themselves gives them a sense of community, comfort, and security. For these people, even the pandemic hasn’t stopped them from wanting to live near…
The US should pursue a COVID-19 booster strategy that focuses on developing new shots that better protect against omicron and its subvariants, according to a recommendation from a Food and Drug Administration advisory committee. The group of independent medical experts voted 19-2 on Tuesday that the COVID-19 boosters should include omicron and its subvariants. They…
Read More “FDA advisers say the US needs updated COVID-19 boosters to fight omicron” »
Emotionally, the slog of the second year of COVID-19 proved as distressing as the shock of the first. As 2021 served up a steady diet of uncertainty, including from the pandemic, the world became a slightly sadder, more worried and more stressed-out place than it was the year before. That pushed the annual Gallup’s Negative…
Read More “The world was unhappier and more stressed than ever — then war, inflation hit” »
US stocks rose on Tuesday, finding support after China moved to ease some COVID-19 restrictions, though worries about both inflation and the threat of recession were seen limiting gains. What’s happening The Dow Jones Industrial Average DJIA rose 150 points, or 0.5%, to 31,589. The S&P 500 SPX gained 12 points, or 0.3%, to trade…
Read More “US stocks bounce back after a sluggish session” »
The Food and Drug Administration and the Centers for Disease Control and Prevention have both authorized Pfizer PFE, + 2.99% and Moderna’s MRNA, + 0.71% COVID-19 vaccines for kids under 5, and the Biden administration said that 10 million initial COVID vaccination doses could start being administered to young children beginning Tuesday, June 21. The…
Read More “COVID vaccines for kids under 5 – what parents need to know” »
A panel of advisers to the Centers for Disease Control and Prevention voted unanimously Thursday to recommend Moderna’s COVID vaccine for children and adolescents aged 6 to 17. The move is expected to lead CDC head Dr. Rochelle Walensky to sign off on the vaccine for that age group, offering a second option along with…
COVID cases are again surging in Europe, driven by the BA.4 and BA.5 subvariants of the omicron variant of the SARS-CoV-2 virus that are deemed to be 10% to 15% more infectious than earlier virus iterations and are spreading fast in. Portugal, France, Germany, Italy, Spain, Greece, the Netherlands and Denmark. In France, cases have…
The US will start vaccinating children below the age of 5 starting this week, after regulatory agencies approved the shots developed by Moderna and Pfizer and BioNTech over the weekend. Advisers to the Centers for Disease Control and Prevention recommended the vaccines for the littlest children, and the final signoff came hours later from Dr….
The Food and Drug Administration took the advice of a panel of advisers and authorized the COVID-19 vaccines developed by BioNTech and Pfizer and by Moderna for children as young as 6 months on Friday, adding the final group to the nation’s vaccine program. The regulator said Moderna’s MRNA The two-dose vaccine is now authorized…
A panel of advisers to the Food and Drug Administration on Wednesday gave its endorsement to both the Moderna and Pfizer vaccines for children below the age of 5, the last group to be added to the vaccine program. The panel voted 21-0 that the benefits of Moderna’s MRNA, -6.37% Two-dose vaccine for children between…
